Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 21:34 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Effects of Amlodipine in the Management of Chronic Heart Failure
NCT00151619 · Rennes University Hospital · PHASE2 · terminated · last registry update 2019-03-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Rennes University Hospital |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1C within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-02-19Phase 3 first posted: University of Auckland, New Zealand, Metronidazole cream + Metronidazole and Diltiazem cream (NCT04276298)
- 2020-01-18Phase 3 first posted: Jaeb Center for Health Research, verapamil 120mg tablet + placebo (NCT04233034)
- 2020-01-18Results posted on the registry: Food and Drug Administration (FDA), Ranolazine + Verapamil (NCT03070470)
- 2020-01-18Results posted on the registry: University of California, San Diego, Ranolazine + Placebo (NCT01505179)
- 2020-01-14Also stopped (terminated): Bispebjerg Hospital, Diltiazem (NCT02158013)
- 2019-09-18Also stopped (withdrawn): Johns Hopkins University, Nimodipine + Verapamil ER (NCT03150524)
- 2019-08-26Results posted on the registry: Mayo Clinic, Rate or Rhythm Control Therapy (NCT00911508)
- 2019-07-30Phase 3 first posted: University of Pennsylvania, Anti Arrhythmics (NCT04037397)
- 2019-07-23Also stopped (terminated): Benjamin Bleier, Verapamil Hydrochloride Intranasal (NCT03102190)
- 2019-07-12Results posted on the registry: Boehringer Ingelheim, Digoxin + Furosemide (NCT03307252)
- 2019-06-21Results posted on the registry: Benjamin Bleier, Verapamil Hydrochloride Intranasal (NCT03102190)
- 2019-04-05Phase 3 first posted: doaa rashwan, Dronedarone + Amiodarone (NCT03905759)
- 2019-01-30Results posted on the registry: University of Alabama at Birmingham, Verapamil + Placebo (NCT02372253)
- 2019-01-23Phase 3 first posted: EMS, LENINGRADO association + Indapamide SR 1.5 MG (NCT03814109)
- 2018-11-20Also stopped (withdrawn): University of South Florida, Diltiazem Hydrochloride + Sugar Pill (NCT01645826)
- 2018-08-09Phase 3 first posted: Hermina Heart Center Kemayoran, Nitroglycerin (NCT03622060)
- 2018-06-26Phase 3 first posted: Samsung Medical Center, Edoxaban + Enoxaparin (NCT03570281)
- 2018-06-14Also stopped (terminated): Benjamin Bleier, Verapamil HCl (NCT02454608)
- 2018-04-11Also stopped (terminated): Center Laboratories, Inc., R-verapamil 75 mg tablet + Placebo (NCT02209155)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision